Authors:
Visonneau, S
Cesano, A
Porter, DL
Luger, SL
Schuchter, L
Kamoun, M
Torosian, MH
Duffy, K
Sickles, C
Stadtmauer, EA
Santoli, D
Citation: S. Visonneau et al., Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer, CLIN CANC R, 6(5), 2000, pp. 1744-1754
Authors:
Stadtmauer, EA
O'Neill, A
Goldstein, LJ
Crilley, PA
Mangan, KF
Ingle, JN
Brodsky, I
Martino, S
Lazarus, HM
Erban, JK
Sickles, C
Glick, JH
Citation: Ea. Stadtmauer et al., Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer., N ENG J MED, 342(15), 2000, pp. 1069-1076
Authors:
Moore, HCF
Mick, R
Solin, LJ
Sickles, C
Mangan, PA
Luger, SM
Fox, KR
Schuchter, LM
Loh, E
Porter, DL
Schuster, S
Buzby, GP
Glatstein, E
Silberstein, LE
Stadtmauer, EA
Citation: Hcf. Moore et al., Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy, ANN ONCOL, 10(8), 1999, pp. 929-936